Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

The habenulo-interpeduncular pathway in nicotine aversion and withdrawal.

Antolin-Fontes B, Ables JL, Görlich A, Ibañez-Tallon I.

Neuropharmacology. 2015 Sep;96(Pt B):213-22. doi: 10.1016/j.neuropharm.2014.11.019. Epub 2014 Dec 2. Review.

2.

New mechanisms and perspectives in nicotine withdrawal.

Jackson KJ, Muldoon PP, De Biasi M, Damaj MI.

Neuropharmacology. 2015 Sep;96(Pt B):223-34. doi: 10.1016/j.neuropharm.2014.11.009. Epub 2014 Nov 26. Review.

3.
4.

Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems.

Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet-Plamondon C, George TP.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:79-85. doi: 10.1016/j.pnpbp.2013.07.010. Epub 2013 Jul 19. Review.

5.
6.

The neuropeptide galanin and variants in the GalR1 gene are associated with nicotine dependence.

Jackson KJ, Chen X, Miles MF, Harenza J, Damaj MI.

Neuropsychopharmacology. 2011 Oct;36(11):2339-48. doi: 10.1038/npp.2011.123. Epub 2011 Jul 27. Erratum in: Neuropsychopharmacology. 2012 Sep;37(10):2345.

7.

Sexually diergic hypothalamic-pituitary-adrenal (HPA) responses to single-dose nicotine, continuous nicotine infusion, and nicotine withdrawal by mecamylamine in rats.

Gentile NE, Andrekanic JD, Karwoski TE, Czambel RK, Rubin RT, Rhodes ME.

Brain Res Bull. 2011 May 30;85(3-4):145-52. doi: 10.1016/j.brainresbull.2011.03.001. Epub 2011 Mar 17.

8.
9.

Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.

Berrendero F, Robledo P, Trigo JM, Martín-García E, Maldonado R.

Neurosci Biobehav Rev. 2010 Nov;35(2):220-31. doi: 10.1016/j.neubiorev.2010.02.006. Epub 2010 Feb 16. Review.

10.
11.

A psychobiological framework of the substrates that mediate nicotine use during adolescence.

O'Dell LE.

Neuropharmacology. 2009;56 Suppl 1:263-78. doi: 10.1016/j.neuropharm.2008.07.039. Epub 2008 Aug 5. Review.

12.

Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs.

Jackson KJ, Martin BR, Changeux JP, Damaj MI.

J Pharmacol Exp Ther. 2008 Apr;325(1):302-12. doi: 10.1124/jpet.107.132977. Epub 2008 Jan 9.

13.

'Nicotine deprivation effect' in rats with intermittent 23-hour access to intravenous nicotine self-administration.

O'Dell LE, Koob GF.

Pharmacol Biochem Behav. 2007 Feb;86(2):346-53. Epub 2007 Jan 13.

14.

Withdrawal from chronic nicotine in adolescent and adult rats.

Wilmouth CE, Spear LP.

Pharmacol Biochem Behav. 2006 Nov;85(3):648-57. Epub 2006 Dec 14.

16.

Mecamylamine attenuates cue-induced reinstatement of nicotine-seeking behavior in rats.

Liu X, Caggiula AR, Yee SK, Nobuta H, Sved AF, Pechnick RN, Poland RE.

Neuropsychopharmacology. 2007 Mar;32(3):710-8. Epub 2006 Jun 21.

17.

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R.

Br J Pharmacol. 2002 Jan;135(2):564-78.

Supplemental Content

Support Center